Kerry Q2 aggressively buys Pinduoduo! Hot AI stock Dell in newly established position

According to the information obtained from the Zhitong Finance and Economics APP, the global alternative asset management giant Carlyle Group Inc submitted its second-quarter position report (13F) as of June 30, 2024, to the U.S. Securities and Exchange Commission (SEC).

Statistics show that Carlyle's total market value of holdings in the second quarter was $1.05 billion, a 34% decrease compared to the total market value of approximately $1.59 billion in the previous quarter. Carlyle only added one new stock to its U.S. stock investment portfolio in the second quarter, reduced holdings in 4 stocks, and completely sold off 2 stocks. The top ten holdings accounted for 92.91% of Carlyle's total market value.

In Carlyle's top ten heavy-weight stocks in Q2, Quidel Corporation (QDEL.US) ranked first with approximately 11.52 million shares, a holding market value of around $382 million, accounting for 28.74% of the portfolio, a decrease of 7.54% in overall holdings from the previous quarter. Public information shows that the global medical diagnostics giant Quidel is committed to providing high-quality diagnostic solutions for healthcare, helping healthcare professionals diagnose and monitor diseases more quickly and accurately. The company's products are typically used for rapid testing of disease markers, pathogens, antibodies, etc., playing an important role in clinical decision-making.

ZoomInfo Technologies (ZI.US) ranked second with approximately 17.24 million shares, a holding market value of around $220 million, accounting for 16.53% of the portfolio, a significant 34.29% reduction in holdings from the previous quarter. Public information shows that it is a software platform company focused on providing market and sales intelligence. Its main business is to provide B2B sales and marketing intelligence data and analysis tools to enterprises through its SaaS (Software as a Service) platform. ZoomInfo's platform gathers a large amount of company information and contact information, helping sales, marketing, and recruitment teams more effectively find potential customers, establish business contacts, and make data-driven decisions.

Soleno Therapeutics Inc (SLNO.US) ranked third, with Carlyle holding approximately 4.07 million shares, a holding market value of around $166 million, accounting for 12.49% of the portfolio, with no change in overall holdings from the previous quarter. Soleno Therapeutics is a biopharmaceutical startup company currently in the clinical research stage.

Pinduoduo (PDD.US) ranked fourth, with approximately 360,000 shares, a holding market value of around $48.13 million, accounting for 3.61% of the portfolio, a sharp increase of 195.24% in holdings from the previous quarter. Chinese e-commerce giant Pinduoduo saw a surge of 14% in the second quarter, with an 8% increase since July Qianbi Private Equity Jinglin Asset also significantly increased its holdings in Pinduoduo in the second quarter, acquiring over 1.57 million shares, with a market value of approximately $209 million, increasing its proportion in the Jinglin investment portfolio by 5.15 percentage points to 18.24% quarter-on-quarter. By the end of the quarter, it held 5.207 million shares, representing a 43.3% increase compared to the previous quarter. As a result, Pinduoduo has become Jinglin's top holding, surpassing Meta, which held the top position in the first quarter.

Broadcom (AVGO.US) ranked fifth, with holdings of approximately 270,000 shares, a market value of around $44.43 million, accounting for 3.34% of the investment portfolio, unchanged from the previous quarter. Broadcom is considered one of the biggest beneficiaries of the AI investment boom, being a key chip supplier to Apple and other major tech companies, as well as a core supplier of Ethernet switch chips for global large AI data centers and AI ASIC custom chips. Driven by strong demand for its chip and software products related to AI business, the company's latest financial data and annual forecast have far exceeded Wall Street analysts' expectations. Despite a recent significant pullback in Broadcom's stock price, it has still risen by as much as 41% year-to-date.

Among the top ten major holdings, Kairen's sixth to tenth largest holdings are: GDS Data (GDS.US), N-able (NABL.US), Phathom Pharmaceuticals (PHAT.US), Verona Pharma (VRNA.US), and Nu Holdings Ltd (NU.US). Among them, Nu Holdings saw a reduction in Kairen's holdings in the second quarter by 23.51%, while the remaining holdings remained unchanged.

From the perspective of changes in holdings, Kairen's largest purchase in the second quarter was Aon PLC (AON.US). Kairen's top five divestments in the second quarter include: Vitru Ltd (VTRU.US), ZoomInfo Technologies (ZI.US), Quidel Corporation (QDEL.US), NuCana PLC ADR (NCNA.US), and Confluent Inc (CFLT.US). Vitru Ltd and Confluent were completely divested by Kairen in the second quarter, with Vitru being an education technology company based in Brazil that provides higher education courses through its online education platform, and Confluent being a software company focused on real-time data streaming platforms.

In addition, Kerry also benefited from the AI investment boom in the second quarter by establishing new positions in AI servers and PC manufacturer Dell (DELL.US), with a holding value of approximately $3.14 million. With the incredibly strong demand for AI servers in major data centers and a deep hardware partnership with NVIDIA over the years, Dell's stock price has risen by over 30% this year